These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2646656)

  • 21. [Glass of water or ablation? - episodes of malignant atrial tachyarrhythmias during swimming in a lake in a woman with overt Wolff-Parkinson-White syndrome and benign palpitations for several decades of life].
    Bodalski R; Maryniak A; Walczak F; Szumowski L; Jedynak Z
    Kardiol Pol; 2008 Dec; 66(12):1346-9. PubMed ID: 19169985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
    Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
    Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of amiodarone in the Wolff-Parkinson-White syndrome.
    Wellens HJ; Lie KI; Bär FW; Wesdorp JC; Dohmen HJ; Düren DR; Durrer D
    Am J Cardiol; 1976 Aug; 38(2):189-94. PubMed ID: 952262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias.
    Schmidt A; König W; Binner L; Mayer U; Stauch M
    Clin Cardiol; 1988 Jul; 11(7):481-5. PubMed ID: 3416512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias.
    Best JF; Rinkenberger R; Lynch L; Dunn M
    Clin Cardiol; 1986 Jun; 9(6):268-71. PubMed ID: 2424656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical results of amiodarone in cardiac arrhythmias: optimal dosing.
    Singh BN; Nademanee K; Kannan R; Ikeda N
    Pacing Clin Electrophysiol; 1984 Jan; 7(1):109-24. PubMed ID: 6199755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
    Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias.
    Vietti-Ramus G; Veglio F; Marchisio U; Burzio P; Latini R
    Int J Cardiol; 1992 Apr; 35(1):77-85. PubMed ID: 1563883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of flecainide in supraventricular arrhythmias].
    Chouty F; Leclercq JF; Coumel P
    Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):237-41. PubMed ID: 3740779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verapamil in cardiac arrhythmias: an overview.
    Vohra J
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():129-34. PubMed ID: 6749351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety.
    Lee KL; Tai YT
    Clin Cardiol; 1997 Apr; 20(4):372-7. PubMed ID: 9098598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy of amiodarone as an antiarrhythmic agent.
    Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV
    Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
    Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R
    Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
    Leak D
    Am Heart J; 1986 Mar; 111(3):456-62. PubMed ID: 3953353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiodarone.
    Smith WC; Reddy CP
    J La State Med Soc; 1989 May; 141(5):35-8. PubMed ID: 2659709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Life-threatening ventricular arrhythmias provoked by amiodarone treatment.
    Kumana CR; Tanser P; Eydt J
    Hum Toxicol; 1985 Mar; 4(2):169-76. PubMed ID: 4007880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.